Reader Question: Routine Additions of 99211 Are Bad Idea

Why This Topic Matters

It helps billing and coding staff recognize when routine lab-visit work may not support an additional E/M service, and it highlights the importance of payer policy, documentation, and CLIA-waived test handling.

Article Sections

1. Question about billing an E/M service with lab-related services

   The article opens with a reader question about pairing an office/outpatient E/M service with laboratory-related services in a practice setting.

2. Documentation and separate service considerations

   This section discusses the need for documentation of a distinct service beyond routine lab-visit workflow and notes when additional provider involvement may affect reporting.

3. Anticoagulation management and payer coverage

   The article addresses payer variation for outpatient anticoagulant management services and notes differences in Medicare handling.

4. Blood draw and specimen collection

   This section covers separate billing considerations for blood collection services and mentions common specimen collection categories.

5. Lab testing and CLIA-waived reporting

   The final section discusses lab testing, CLIA-waived testing status, waived test reporting, and the use of approved methods and waiver-related billing indicators.